Mar González-Fernández, Daniel Vázquez-Coto, Guillermo M Albaiceta, Laura Amado-Rodríguez, Marta G Clemente, Lucinda Velázquez-Cuervo, Claudia García-Lago, Juan Gómez, Eliecer Coto
{"title":"阿斯图里亚斯(西班牙北部)的染色体 Y 单倍群及其与严重 COVID-19 的关系。","authors":"Mar González-Fernández, Daniel Vázquez-Coto, Guillermo M Albaiceta, Laura Amado-Rodríguez, Marta G Clemente, Lucinda Velázquez-Cuervo, Claudia García-Lago, Juan Gómez, Eliecer Coto","doi":"10.1007/s00438-024-02143-4","DOIUrl":null,"url":null,"abstract":"<p><p>The main objective of this study was to determine whether the common Y-haplogroups were be associated with the risk of developing severe COVID-19 in Spanish male. We studied 479 patients who required hospitalization due to COVID-19 and 285 population controls from the region of Asturias (northern Spain), They were genotyped for several polymorphisms that define the common European Y-haplogroups. We compared the frequencies between patients and controls aged ≤ 65 and >65 years. There were no different haplogroup frequencies between the two age groups of controls. Haplogroup R1b was less common in patients aged ≤65 years. Haplogroup I was more common in the two patient´s groups compared to controls (p = 0.02). Haplogroup R1b was significantly more frequent among hypertensive patients, without difference between the hypertensive and normotensive controls. This suggested that R1b could increase the risk for severe COVID-19 among male with pre-existing hypertension. In conclusion, we described the Y-haplogroup structure among Asturians. We found an increased risk of severe COVID-19 among haplogroup I carriers, and a significantly higher frequency of R1b among hypertensive patients. These results indicate that Y-chromosome variants could serve as markers to define the risk of developing a severe form of COVID-19.</p>","PeriodicalId":18816,"journal":{"name":"Molecular Genetics and Genomics","volume":"299 1","pages":"49"},"PeriodicalIF":2.3000,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11069473/pdf/","citationCount":"0","resultStr":"{\"title\":\"Chromosome-Y haplogroups in Asturias (Northern Spain) and their association with severe COVID-19.\",\"authors\":\"Mar González-Fernández, Daniel Vázquez-Coto, Guillermo M Albaiceta, Laura Amado-Rodríguez, Marta G Clemente, Lucinda Velázquez-Cuervo, Claudia García-Lago, Juan Gómez, Eliecer Coto\",\"doi\":\"10.1007/s00438-024-02143-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The main objective of this study was to determine whether the common Y-haplogroups were be associated with the risk of developing severe COVID-19 in Spanish male. We studied 479 patients who required hospitalization due to COVID-19 and 285 population controls from the region of Asturias (northern Spain), They were genotyped for several polymorphisms that define the common European Y-haplogroups. We compared the frequencies between patients and controls aged ≤ 65 and >65 years. There were no different haplogroup frequencies between the two age groups of controls. Haplogroup R1b was less common in patients aged ≤65 years. Haplogroup I was more common in the two patient´s groups compared to controls (p = 0.02). Haplogroup R1b was significantly more frequent among hypertensive patients, without difference between the hypertensive and normotensive controls. This suggested that R1b could increase the risk for severe COVID-19 among male with pre-existing hypertension. In conclusion, we described the Y-haplogroup structure among Asturians. We found an increased risk of severe COVID-19 among haplogroup I carriers, and a significantly higher frequency of R1b among hypertensive patients. These results indicate that Y-chromosome variants could serve as markers to define the risk of developing a severe form of COVID-19.</p>\",\"PeriodicalId\":18816,\"journal\":{\"name\":\"Molecular Genetics and Genomics\",\"volume\":\"299 1\",\"pages\":\"49\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2024-05-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11069473/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Genetics and Genomics\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1007/s00438-024-02143-4\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Genetics and Genomics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s00438-024-02143-4","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
这项研究的主要目的是确定常见的 Y 单倍群是否与西班牙男性罹患严重 COVID-19 的风险有关。我们对阿斯图里亚斯地区(西班牙北部)的 479 名因 COVID-19 而需要住院治疗的患者和 285 名对照人群进行了研究,并对确定欧洲常见 Y 单倍群的几种多态性进行了基因分型。我们比较了年龄小于 65 岁和大于 65 岁的患者和对照组的频率。两个年龄组的对照组之间没有不同的单倍群频率。单倍群 R1b 在年龄≤65 岁的患者中较少见。与对照组相比,单倍群 I 在两组患者中更为常见(p = 0.02)。单倍群 R1b 在高血压患者中更为常见,而在高血压和正常血压对照组中没有差异。这表明,R1b 可能会增加原有高血压男性患严重 COVID-19 的风险。总之,我们描述了阿斯图里亚斯人的 Y 单倍群结构。我们发现单倍群 I 携带者罹患严重 COVID-19 的风险增加,而高血压患者中 R1b 的频率明显较高。这些结果表明,Y 染色体变异可作为确定严重 COVID-19 发病风险的标记。
Chromosome-Y haplogroups in Asturias (Northern Spain) and their association with severe COVID-19.
The main objective of this study was to determine whether the common Y-haplogroups were be associated with the risk of developing severe COVID-19 in Spanish male. We studied 479 patients who required hospitalization due to COVID-19 and 285 population controls from the region of Asturias (northern Spain), They were genotyped for several polymorphisms that define the common European Y-haplogroups. We compared the frequencies between patients and controls aged ≤ 65 and >65 years. There were no different haplogroup frequencies between the two age groups of controls. Haplogroup R1b was less common in patients aged ≤65 years. Haplogroup I was more common in the two patient´s groups compared to controls (p = 0.02). Haplogroup R1b was significantly more frequent among hypertensive patients, without difference between the hypertensive and normotensive controls. This suggested that R1b could increase the risk for severe COVID-19 among male with pre-existing hypertension. In conclusion, we described the Y-haplogroup structure among Asturians. We found an increased risk of severe COVID-19 among haplogroup I carriers, and a significantly higher frequency of R1b among hypertensive patients. These results indicate that Y-chromosome variants could serve as markers to define the risk of developing a severe form of COVID-19.
期刊介绍:
Molecular Genetics and Genomics (MGG) publishes peer-reviewed articles covering all areas of genetics and genomics. Any approach to the study of genes and genomes is considered, be it experimental, theoretical or synthetic. MGG publishes research on all organisms that is of broad interest to those working in the fields of genetics, genomics, biology, medicine and biotechnology.
The journal investigates a broad range of topics, including these from recent issues: mechanisms for extending longevity in a variety of organisms; screening of yeast metal homeostasis genes involved in mitochondrial functions; molecular mapping of cultivar-specific avirulence genes in the rice blast fungus and more.